Search Results

10 results for population screening

Rare Diseases, Genomics and Public Health: An Expanding Intersection

Rare Diseases with DNA and an intersection

Rare Disease Day is celebrated on the last day of February each year. On that day, millions of patients and their families around the world share their stories in order to raise awareness about rare diseases and their impact. There are thousands of diseases that are individually rare but collectively common. In the United States,

Posted on by Muin J. Khoury, Director, Office of Public Health Genomics; Rodolfo Valdez, epidemiologist, National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention1 CommentTags

Public Health Genomics 2015: Looking Back, Looking Ahead

2015 - the 0 has DNA on it and a 6 is sliding down - people in the foreground

In 2015, the United States launched the precision medicine initiative that includes a cancer component and a national cohort research study of one million or more people. While much of this initiative will take years to develop outputs for use in health care, a public health perspective is crucial to ensure the initiative’s success in

Posted on by Muin J Khoury, Director, Office of Public Health Genomics, Centers for Disease Control and PreventionTags

National Family History Day 2015: Thinking globally and acting locally

Multi Generation Family Celebrating Thanksgiving

Though you probably will not find greeting cards in stores celebrating this fact, Thanksgiving has been known as National Family History Day in the U.S. since 2004.  The Office of the U.S. Surgeon General and many federal, state and private partners have marked each year with events and announcements promoting the collection and use of family

Posted on by W. Gregory Feero, MD, PhD, Maine Dartmouth Family Medicine ResidencyTags , ,

Precision Medicine vs. Public Health: a False Dichotomy?

a crowd of people with two individuals circled in red and arrows pointed at them

The recent focus on precision medicine has attracted criticism from the public health community that firmly believes that health is determined by far more than health care, and that more sophisticated medical technologies may not adequately address important determinants of population health. There is no argument that a focus on the wider environmental, structural and

Posted on by Ron Zimmern, PHG Foundation and Muin J. Khoury, Office of Public Health Genomics, Centers for Disease Control and Prevention

Precision Medicine, Implementation Science and Public Health: How Do We Scale Up From 1 Million to 300 Million?

figure with magnifying glass looking at the US map

Planning for the 2015 Presidential Precision Medicine Initiative is in full swing. After the initial announcement in January 2015, several workshops were held to help in design and execution of the longitudinal cohort study of 1 million persons. The workshops covered important topics including a Building a Precision Medicine Research Cohort, Scientific Opportunities, Digital Health Data,

Posted on by Muin J Khoury, Director, Office of Public Health Genomics, Centers for Disease Control and Prevention1 CommentTags

Precision Medicine and Public Health: Improving Health Now While Generating New Knowledge for the Future

a crowd

In a previous post, I commented on the importance of a public health perspective to ensure the success of the proposed precision medicine large national research cohort. Here I offer additional thoughts on the need to balance short term public health gains with long term knowledge generation from this effort.

Posted on by Muin J Khoury, Director, Office of Public Health Genomics, Centers for Disease Control and PreventionTags

The Ultimate Selfie

girl seeing a reflection in the water with DNA swimming in it

Now within reach, our personal genomic sequence offers an incredible reflection of who we are, and great promise to improve human health, but there are serious concerns about embracing it too quickly. Empowered Consumers in the Era of Me If social media is any indication, we, like Narcissus of ancient myth, are surely self-obsessed creatures.

Posted on by Scott Bowen and Muin J Khoury, Office of Public Health Genomics, Centers for Disease Control and Prevention3 CommentsTags , , , ,

Precision Public Health and Precision Medicine: Two Peas in a Pod

two peas is a pod: first pea has a crowd of figures with one under a magnifying glass- second pod has that individual being examined by a doctor- the pod has DNA on it

  The 2015 US Precision Medicine Initiative promises a new era of biomedical research and its application in health care. The initiative is enabled by rapid advances in biomedical sciences, including genomics and bioinformatics, as well as the progress in communication, information technologies and data science. Targeted cancer therapies are a near term goal for

Posted on by Muin J Khoury, Director, Office of Public Health Genomics, Centers for Disease Control and PreventionTags ,

Human Disease and Bad Luck: Acting on Genetic & Environmental Factors to Reduce Cancer Risk

a pair of die, DNA and a hand holding a globe with a tree inside wiht sequencing in the background

In January 2015, a paper in Science created a “buzz” in the scientific community and the media. Based on statistical modelling, the authors suggested that “only a third of the variation in cancer risk among tissues is attributable to environmental factors or inherited predispositions. The majority is due to ‘bad luck,’ that is, random mutations

Posted on by Muin J Khoury, Director, Office of Public Health Genomics and Lisa C. Richardson, Director, Division of Cancer Prevention and Control, Centers for Disease Control and Prevention1 Comment

The Success of Precision Medicine Requires a Public Health Perspective

a magifying glass focusing on a figure in red with surrounding figures in blue

The announcement of a new major US Precision Medicine initiative comes more than a decade after the completion of the Human Genome Project, the ambitious project that culminated in sequencing all 3 billion base pairs of our genome. Continuous improvement in the quality of sequencing, dramatic reduction in price, and ongoing advances in multiple sectors

Posted on by Muin J Khoury, Director, Office of Public Health Genomics, Centers for Disease Control and Prevention1 CommentTags , ,